TMCnet News
Hyperthyroidism Drug Profiles and Clinical Trials Report - Global Trends and Analysis Review, H2 2017 - Research and MarketsThe "Hyperthyroidism Drug Profiles and Clinical Trials - Global Trends and Analysis Review, H2 2017" report has been added to Research and Markets' offering. Hyperthyroidism is a common form of thyroid disorder, which results from overactive thyroid functioning and is mostly observed in women, older population and patients with other thyroid issues. Extra secretion of thyroid hormones leads to speeding up of metabolism in the body. Accordingly, patients witness symptoms of anxiety, rapid heartbeat, shivering, excessive sweat excretion, weight loss and insomnia. Auto-immune disorders including Graves' disease are a common cause of the condition. The disease leads the body to produce an anti-body termed thyroid-stimulating immunoglobulin (TSI (News - Alert)). The TSI results in the thyroid secreting additional thyroid hormones. In addition, lumps on thyroid gland and arrhythmia medications are also observed to cause hyperthyroidism. Treatment options vary from patient to patient based on the condition including medication to reduce T3 and T4 hormone secretion, radioiodine and surgery. Hyperthyroidism clinical trials report provides comprehensive analysis and trends in global Hyperthyroidism disease clinical trials. The research work analyzes the evolution of Hyperthyroidism clinical trial trends across countries and regions. The report focuses on drugs and therapies being evaluated for Hyperthyroidism treatment in active clinical development phases including phase 1, phase 2, hase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, phases, trial status and sponsor types. Major drugs under development in Hyperthyroidism are provided in the report along with their details of Mechanism of Action, Route of Administration, Target (News - Alert), therapy, molecule and class. Scope of the Report:
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/research/wj9tlw/hyperthyroidism View source version on businesswire.com: http://www.businesswire.com/news/home/20171120006012/en/ |